BR9604870A -
Pharmaceutical composition compounds processes for preparing the compounds and for treating a human or animal individual suffering from a clinical condition mediated by the selective inhibition of Cox-2 from an inflammatory disorder and use of a compound
- Google Patents
Pharmaceutical composition compounds processes for preparing the compounds and for treating a human or animal individual suffering from a clinical condition mediated by the selective inhibition of Cox-2 from an inflammatory disorder and use of a compound
Info
Publication number
BR9604870A
BR9604870ABR9604870ABR9604870ABR9604870ABR 9604870 ABR9604870 ABR 9604870ABR 9604870 ABR9604870 ABR 9604870ABR 9604870 ABR9604870 ABR 9604870ABR 9604870 ABR9604870 ABR 9604870A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority claimed from PCT/EP1996/001438external-prioritypatent/WO1996031509A1/en
Publication of BR9604870ApublicationCriticalpatent/BR9604870A/en
BR9604870A1995-04-041996-04-02
Pharmaceutical composition compounds processes for preparing the compounds and for treating a human or animal individual suffering from a clinical condition mediated by the selective inhibition of Cox-2 from an inflammatory disorder and use of a compound
BR9604870A
(en)
Pharmaceutical composition compounds processes for preparing the compounds and for treating a human or animal individual suffering from a clinical condition mediated by the selective inhibition of Cox-2 from an inflammatory disorder and use of a compound
Compound pharmaceutical formulation use of a compound and processes for the preparation of a compound and for treatment of a human or animal individual suffering from a disorder mediated by aberrant protein tyrosine kinase activity
Compound processes to prepare it for the treatment or prevention of diseases of the endocrine system and for the manufacture of pharmaceutical drugs and the use of a compound
Pharmaceutical formulation compound uses a compound processes of treatment of a human or animal suffering from a mediated by abnormal activity of protein tyrosine kinase and for the preparation of a compound
Compound use of a compound Pharmaceutical composition and processes for the treatment of a patient suffering from pain and for the preparation of a compound
Compound use of a compound pharmaceutical composition aerosol combination pharmaceutical formulation and processes for the treatment of a human or animal individual with an anti-inflammatory and / or allergic condition and for the preparation of a compound
Benzonitriles and benzofluorides, drugs comprising the compounds, pharmaceutical compositions containing the compounds, and use of the compounds for the preparation of pharmaceutical preparations
Pharmaceutical composition compounds processes for preparing the compounds and for treating a human or animal individual suffering from a clinical condition mediated by the selective inhibition of Cox-2 from an inflammatory disorder and use of a compound
Legal Events
Date
Code
Title
Description
FB36
Technical and formal requirements: requirement - article 36 of industrial property law
B11B
Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements